Glycated haemoglobin versus fasting plasma glucose for type 2 diabetes point of care screening: a decision model cost-effectiveness analysis

Introduction Whereas fasting plasma glucose (FPG) is cheaper, the glycated haemoglobin (HBA1c) test, which does not require fasting, is more convenient for diabetes screening and could be available to patients throughout the day. In this study, we compared the cost effectiveness of the HBA1c test to...

Full description

Saved in:
Bibliographic Details
Published in:BMC health services research 2025-05, Vol.25 (1), p.664-9, Article 664
Main Authors: Kasujja, Francis Xavier, Daivadanam, Meena, Mayega, Roy William, Nuwaha, Fred, Kusolo, Ronald, Ekirapa, Elizabeth
Format: Article
Language:English
Subjects:
Adult
Aged
Analysis
Blood Glucose - analysis
Blood sugar
Capital costs
Comparative analysis
Cost benefit analysis
Cost-Effectiveness Analysis
Decision Support Techniques
Dextrose
Diabetes
Diabetes detection
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - diagnosis
Diabetes tests
Diabetes therapy
Diagnosis
Economic aspects
Fasting - blood
Female
FPG
Glucose
Glycated Hemoglobin - analysis
Glycosylated hemoglobin
HBA1c
Health Administration
Health aspects
Health facilities
Health Informatics
Hemoglobin
Hospitals
Humans
Male
Mass Screening - economics
Mass Screening - methods
Measurement
Medical care, Cost of
Medical screening
Medicine
Medicine & Public Health
Middle Aged
Mortality
Nursing Research
Point-of-Care Systems - economics
Public Health
Sickle cell disease
Type 2 diabetes
Uganda
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!